New technique yields fast results in drug, biomedical testing
10/13/2014
A new technique makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine, representing a potential tool for...
Long-term treatment success using gene therapy to correct a lethal metabolic disorder
10/13/2014
Excessive and often lethal blood levels of bilirubin can result from mutations in a single gene that are the cause of the metabolic disease known as Crigler-Najjar syndrome type 1 (CNS1).
Metamark has announced the nationwide availability of ProMark™, the first-of-its-kind protein-based biopsy test designed to improve the accuracy of prognosis for men diagnosed with prostate...
Millennium: The Takeda Oncology Company with its parent company, Takeda Pharmaceutical Company Limited, has announced that the U.S.
A study by Queensland University of Technology (QUT) health researchers in collaboration with The Wesley Hospital Kim Walters Choices Program has found that women treated for breast cancer improved...
Pfizer Inc. is uniting with leaders in the breast cancer community in a public call-to-action to expand the breast cancer dialogue to include metastatic breast cancer.
New knowledge about anemia and fatigue in cancer patients
10/13/2014
Many patients with cancer experience low blood counts, which causes weakness and fatigue.
New technique yields fast results in drug, biomedical testing
10/13/2014
A new technique makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine, representing a potential tool for...
Long-term treatment success using gene therapy to correct a lethal metabolic disorder
10/13/2014
Excessive and often lethal blood levels of bilirubin can result from mutations in a single gene that are the cause of the metabolic disease known as Crigler-Najjar syndrome type 1 (CNS1).
Unusual skin cancer linked to chronic allergy from metal orthopedic implant
10/13/2014
Activated immune cells, shown in red and green, cluster at the site of an allergic skin rash. Scientists have learned that this inflammation can promote skin tumor formation if it persists.